Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials
- 1 July 1999
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 35 (7) , 1059-1064
- https://doi.org/10.1016/s0959-8049(99)00076-3
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- A Randomized Trial Comparing Adjuvant Fluorouracil, Epirubicin, and Mitomycin with No Treatment in Operable Gastric CancerChemotherapy, 1996
- Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer.Journal of Clinical Oncology, 1995
- Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A southwest oncology group studyAnnals of Surgical Oncology, 1995
- Current options in the management of gastrointestinal cancerAnnals of Oncology, 1995
- Adjuvant chemotherapy for resectable gastric cancer: A preliminary reportJournal of Surgical Oncology, 1994
- Adjuvant treatment in gastric cancerCancer Treatment Reviews, 1994
- Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer.Journal of Clinical Oncology, 1994
- Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.Journal of Clinical Oncology, 1993
- Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancerThe Lancet, 1992
- A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancerCancer, 1991